1. Home
  2. SIBN vs VALN Comparison

SIBN vs VALN Comparison

Compare SIBN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • VALN
  • Stock Information
  • Founded
  • SIBN 2008
  • VALN 2012
  • Country
  • SIBN United States
  • VALN France
  • Employees
  • SIBN N/A
  • VALN N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SIBN Health Care
  • VALN Health Care
  • Exchange
  • SIBN Nasdaq
  • VALN Nasdaq
  • Market Cap
  • SIBN 805.4M
  • VALN 542.5M
  • IPO Year
  • SIBN 2018
  • VALN 2021
  • Fundamental
  • Price
  • SIBN $17.32
  • VALN $6.08
  • Analyst Decision
  • SIBN Strong Buy
  • VALN Strong Buy
  • Analyst Count
  • SIBN 5
  • VALN 3
  • Target Price
  • SIBN $24.40
  • VALN $15.33
  • AVG Volume (30 Days)
  • SIBN 490.0K
  • VALN 14.6K
  • Earning Date
  • SIBN 08-04-2025
  • VALN 08-12-2025
  • Dividend Yield
  • SIBN N/A
  • VALN N/A
  • EPS Growth
  • SIBN N/A
  • VALN N/A
  • EPS
  • SIBN N/A
  • VALN N/A
  • Revenue
  • SIBN $176,601,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • SIBN $19.48
  • VALN $18.74
  • Revenue Next Year
  • SIBN $16.86
  • VALN $29.26
  • P/E Ratio
  • SIBN N/A
  • VALN N/A
  • Revenue Growth
  • SIBN 22.60
  • VALN 21.64
  • 52 Week Low
  • SIBN $11.70
  • VALN $3.62
  • 52 Week High
  • SIBN $20.05
  • VALN $8.66
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 43.88
  • VALN 55.66
  • Support Level
  • SIBN $17.94
  • VALN $5.82
  • Resistance Level
  • SIBN $18.87
  • VALN $6.19
  • Average True Range (ATR)
  • SIBN 0.67
  • VALN 0.29
  • MACD
  • SIBN -0.09
  • VALN 0.06
  • Stochastic Oscillator
  • SIBN 34.77
  • VALN 72.36

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: